Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Clin Endocrinol Metab ; 93(9): 3604-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18559919

ABSTRACT

CONTEXT: Pregnant tissues express corticotropin-releasing factor (CRF), a peptide modulating fetal and placental ACTH and cortisol secretion. These actions are modulated by the locally expressed CRF-binding protein (CRF-BP). OBJECTIVE: The objective of the study was to determine whether CRF, CRF-BP, ACTH, and cortisol concentrations change in amniotic fluid and umbilical cord plasma in the presence of intraamniotic infection/inflammation (IAI) in women with spontaneous labor at term. DESIGN: This was a cross-sectional study. SETTING: The study was conducted at a tertiary referral center for obstetric care. PATIENTS: Patients included women in active labor at term with (n = 39) and without (controls; n = 78) IAI. MAIN OUTCOME MEASURES: Amniotic fluid and umbilical cord plasma concentrations of CRF, CRF-BP, ACTH, and cortisol measured by RIA and immunoradiometric assays were measured. RESULTS: In patients with IAI, amniotic fluid CRF (0.97 +/- 0.18 ng/ml) and CRF-BP (33.06 +/- 5.54 nmol/liter) concentrations were significantly (P < 0.001) higher than in controls (CRF: 0.32 +/- 0.04 ng/ml; CRF-BP: 14.69 +/- 2.79 ml). The umbilical cord plasma CRF and CRF-BP concentrations were significantly (P < 0.001 for all) higher in women with IAI than in controls (CRF: 2.96 +/- 0.35 ng/ml vs. 0.38 +/- 0.18 ng/ml; CRF-BP: 152.12 +/- 5.94 nmol/liter vs. 106.9 +/- 5.97 nmol/liter). In contrast, amniotic fluid and umbilical cord plasma ACTH and cortisol concentrations did not differ between groups. CONCLUSIONS: Amniotic fluid and umbilical cord plasma CRF and CRF-BP concentrations are increased in women with spontaneous labor at term and IAI. CRF-BP may modulate CRF actions on ACTH and cortisol secretion, playing a pivotal role in limiting the inflammatory process and thus avoiding an overactivation of the fetal/placental hypothalamus-pituitary-adrenal axis at birth.


Subject(s)
Adrenocorticotropic Hormone/analysis , Amniotic Fluid/chemistry , Bacterial Infections/pathology , Carrier Proteins/analysis , Corticotropin-Releasing Hormone/analysis , Fetal Blood/chemistry , Hydrocortisone/analysis , Inflammation/pathology , Term Birth , Adrenocorticotropic Hormone/blood , Adrenocorticotropic Hormone/metabolism , Amniotic Fluid/cytology , Amniotic Fluid/microbiology , Bacterial Infections/blood , Bacterial Infections/metabolism , Carrier Proteins/blood , Carrier Proteins/metabolism , Case-Control Studies , Corticotropin-Releasing Hormone/blood , Corticotropin-Releasing Hormone/metabolism , Cross-Sectional Studies , Female , Fetal Blood/metabolism , Humans , Hydrocortisone/blood , Hydrocortisone/metabolism , Inflammation/blood , Inflammation/metabolism , Pregnancy , Pregnancy Complications, Infectious/blood , Pregnancy Complications, Infectious/microbiology , Pregnancy Complications, Infectious/pathology , Term Birth/blood , Term Birth/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...